Results

Total Results: 1,220 records

Showing results for "adverse events".
Users also searched for: patient safety indicators

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_executive.pdf
    January 01, 2020 - What adverse events are collected in clinical studies (Phases I–IV) and in observational studies containing … Our results support most findings of the IOM report, add conclusions on some adverse events for which … Broad categories such as “injection-related adverse events,” “systemic adverse events,” “one or more … adverse events,” or “serious adverse events” were reported rather than specific AEs. … Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. May 28, 2009. 19.
  2. effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
    March 01, 2010 - The adverse events include altered glucose, diabetes mellitus, lymphoid overgrowth, and malignancy. … KQ 6: In patients with CF, how are efficacy, effectiveness, safety, or adverse events impacted by rhGH … KQ 7: In patients with CF, how do the efficacy, effectiveness, safety, or adverse events of treatment … Key question 6: In patients with CF, how are efficacy, effectiveness, safety, or adverse events impacted … Key question 7: In patients with CF, how do the efficacy, effectiveness, safety, or adverse events of
  3. effectivehealthcare.ahrq.gov/products/mhs4-computerized-cds/protocol
  4. Gout Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout_executive.pdf
    March 01, 2016 - KQ1, 2 KQ1, 2 Adverse Events Discon�nua�on of An�-inflammatory Therapy KQ5b KQ5b (including presence … Observational studies were also included for rare adverse events. … The most commonly reported adverse events in trials of febuxostat were abdominal pain, diarrhea, and … • High-strength evidence supports a lack of difference in overall adverse events between allopurinol … Adverse events associated with colchicine drug interactions: Analysis of the public version of the
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pneumonia-antibiotic-treatment_research-protocol.pdf
    July 19, 2013 - events for patients with HAP, which may result in lower health care costs. … Rates of antibiotic-related adverse events? … Rates of antibiotic-related adverse events? … Question 3 Does the evidence for morbidity, mortality, antibiotic-related adverse events, clinical … events (e.g., organ toxicityd) Subgroups:   • HAP, VAP, and HCAP • Immunocompromised •
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_disposition-comments.pdf
    December 20, 2012 - We agree that interventions for managing adverse events may be considered patient- level interventions … effects” “adverse events”, or “side effects.” … We have replaced adverse effects with “adverse events” throughout the document. … We agree that interventions for managing adverse events may be considered patient- level interventions … We agree that interventions for managing adverse events may be considered patient- level interventions
  7. effectivehealthcare.ahrq.gov/sites/default/files/methods-report-web-interactive-presentation-appendix-a.pdf
    May 29, 2025 - categories) for • Cure, improvement, satisfaction (n=117 studies) • Quality of life (n=84 studies) • Adverseevents (n=138 studies) 4 An interactive tool 5 Level 1 Evidence Graph for specific interventions
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
    November 03, 2011 - o Treatment discontinuation due to adverse effects. … For categorical variables we will abstract the number of events among treatment groups to calculate … percent CI, we will calculate the relative risk and absolute risk difference from the abstracted events … Time course of adverse events most commonly associated with topiramate for migraine prevention. … A systematic review of adverse events in placebo groups of anti-migraine clinical trials.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
    December 31, 2013 - events when compared with statin monotherapy. … The CER will examine surrogate markers of CHD events including lipid levels and atherosclerosis, as … Ridker PM, Rifai N, Pfeffer MA, et al; Cholesterol and Recurrent Events Investigators. … Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol … Rosuvastatin to  prevent vascular events in men and women with elevated C-­‐reactive protein.
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
    January 01, 2008 - the cost of treatment, the severity of diseases that HSCT is used to treat, and the prevalence of adverseevents associated with HSCT, a comprehensive review that focuses on both benefits and harms across
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0086_04-01-2009.pdf
    January 01, 2009 - any commonly used dietary supplements decrease the effectiveness of these medications or increase adverseevents.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/polyunsaturated-fatty-protocol.pdf
    January 01, 2024 - Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events Evidence-based … Project Title: Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular Events … determinant of plasma lipid and lipoprotein concentrations, and subsequent cardiovascular (CV) disease events … o Atherosclerotic cardiovascular disease (total) o Major adverse cardiac (or cerebral) events … – total cholesterol; Tg = Triglycerides/Triacylglycerols; apoA = apolipoprotein; MAC[C]E = Major adverse
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
    September 01, 2010 - events.13 The first anti-tumor necrosis factor-α (anti- TNF) biologic, infliximab, was approved for … events.13 Treatment guidelines and meta-analyses on the management of Crohn’s disease. … events. … events, and patient-reported outcomes. … events
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-protocol.pdf
    July 01, 2023 - scan patient data for signs of clinical deterioration in order to alert a clinician of a potential adverse … .9-11 One study found no statistical improvement in the number of rescue events but did find that the … Activation of rapid response system (a process measure) • Cardiorespiratory arrest • Serious adverse … Effectiveness of continuous or intermittent vital signs monitoring in preventing adverse events on … scan patient data for signs of clinical deterioration in order to alert a clinician of a potential adverse
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
    May 01, 2012 - However, adverse events, especially irritability and moodiness, can lead to discontinuation, and use … Few serious adverse events were noted. … Fewer individuals discontinue psychostimulants and ATX than guanfacine XR due to adverse events. … We have identified key clinical and adverse events outcomes as reported in the draft review, which is … Among individuals ages 6 years or older with ADHD, what are the adverse events and noncompliance rates
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol-amendment.pdf
    January 08, 2025 - We will create a comprehensive list of pertinent adverse events using the Common Terminology Criteria … for Adverse Events (CTCAE) to ease in their abstraction. … events. … Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0. November 27, 2017. … The Development of the McHarm Quality Assessment Scale for adverse events: Delphi Consensus on important
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol.pdf
    June 10, 2024 - We will create a comprehensive list of pertinent adverse events using the Common Terminology Criteria … for Adverse Events (CTCAE) to ease in their abstraction. … events. … Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0. November 27, 2017. … The Development of the McHarm Quality Assessment Scale for adverse events: Delphi Consensus on important
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
    January 01, 2016 - events, mortality, imaging quality, and diagnostic accuracy. … Food and Drug Administration Adverse Event Reporting System (AERS). … events, imaging quality, and diagnostic accuracy. … events (12 studies), or image and diagnostic quality (2 studies). … , mortality, need for renal replacement therapy, or other adverse events.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stroke-atrial-fibrillation_executive.pdf
    August 01, 2013 - 1.00 to 1.91) Hospitalization 1 (12,098) SOE = High No difference (RR 0.97; 95% CI 0.92 to 1.03) Adverse … No differences in liver function or other adverse events between therapies. … No differences in liver function or other adverse events between therapies. … events 2 (18,423) SOE = Moderate Adverse events occurred in almost equal proportions of patients in … events 1 (5,599) SOE = Moderate No differences in liver function or other adverse events between
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
    January 09, 2020 - In addition to effectiveness, decisionmakers need information on potential adverse risks, and special … Pain, function, pain relief satisfaction and quality of life, harms/adverse events (including withdrawal … events KQ 3: Non-invasive non-pharm Therapy: Pain, function, pain relief satisfaction, quality of … life and quality of life, harms, adverse events None Timing At the following intervals: < 1 day … events in patients with migraine.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: